Madrigal Pharmaceuticals, Inc.
DE ˙ DB ˙ US5588681057
426,20 € ↑6,40 (1,52%)
2026-06-04
DEL PRIS
SecurityDE:YDO1 / Madrigal Pharmaceuticals, Inc.
InstitutionGoldman Sachs Group Inc
Latest Disclosed Ownership277,371 shares
Latest Disclosed Value $ 145,195,396
Goldman Sachs Group Inc ownership in YDO1 / Madrigal Pharmaceuticals, Inc.

On May 15, 2026 - Goldman Sachs Group Inc filed a 13F-HR form disclosing ownership of 277,371 shares of Madrigal Pharmaceuticals, Inc. (DE:YDO1) valued at $124,900,161 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 305,831 shares of Madrigal Pharmaceuticals, Inc.. This represents a change in shares of -9.31% during the quarter. The current value of the position is $118,215,520 USD.

Goldman Sachs Group Inc has a history of taking positions in derivatives of the underlying security (YDO1) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:YDO1 / Madrigal Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F MADRIGAL PHARMACEUTICALS CMN 558868105 277,371 -28,460 -9.31 145,195 -18.47 0.0039
2026-02-10 2025-12-31 13F MADRIGAL PHARMACEUTICALS CMN 558868105 305,831 -80,269 -20.79 178,098 0.57 0.0220
2025-11-14 2025-09-30 13F MADRIGAL PHARMACEUTICALS CMN 558868105 386,100 196,260 103.38 177,089 208.23 0.0217
2025-08-14 2025-06-30 13F MADRIGAL PHARMACEUTICALS CMN 558868105 189,840 201 0.11 57,453 -8.53 0.0078
2025-06-27 2025-03-31 13F/A-2 MADRIGAL PHARMACEUTICALS CMN 558868105 189,639 -41,811 -18.06 62,814 -12.05 0.0102
2025-05-16 2025-03-31 13F/A-1 MADRIGAL PHARMACEUTICALS CMN 558868105 189,639 -41,811 62,814 0.0102
2025-05-09 2025-03-31 13F MADRIGAL PHARMACEUTICALS CMN 558868105 189,639 -41,811 62,814 0.0019
2025-02-11 2024-12-31 13F MADRIGAL PHARMACEUTICALS CMN 558868105 231,450 -8,330 -3.47 71,419 40.35 0.0113
2024-11-14 2024-09-30 13F MADRIGAL PHARMACEUTICALS CMN 558868105 239,780 68,329 39.85 50,886 5.94 0.0082
2024-08-13 2024-06-30 13F MADRIGAL PHARMACEUTICALS CMN 558868105 171,451 79,662 86.79 48,034 95.97 0.0081
2024-05-15 2024-03-31 13F MADRIGAL PHARMACEUTICALS CMN 558868105 91,789 6,686 7.86 24,511 24.48 0.0043
2024-05-14 2023-12-31 13F/A-2 MADRIGAL PHARMACEUTICALS CMN 558868105 85,103 8,691 11.37 19,691 76.46 0.0036
2024-03-01 2023-12-31 13F/A-1 MADRIGAL PHARMACEUTICALS CMN 558868105 85,103 8,691 19,691 0.0035
2024-02-13 2023-12-31 13F MADRIGAL PHARMACEUTICALS CMN 558868105 85,103 8,691 19,691 0.0035
2024-05-15 2023-09-30 13F/A-1 MADRIGAL PHARMACEUTICALS CMN 558868105 76,412 6,103 8.68 11,159 -31.29 0.0024
2023-11-14 2023-09-30 13F MADRIGAL PHARMACEUTICALS CMN 558868105 76,412 6,103 11,159 0.0022
2024-05-14 2023-06-30 13F/A-1 MADRIGAL PHARMACEUTICALS CMN 558868105 70,309 -72,682 -50.83 16,241 -53.11 0.0035
2023-08-15 2023-06-30 13F MADRIGAL PHARMACEUTICALS CMN 558868105 70,309 -72,682 16,241 0.0033
2024-05-14 2023-03-31 13F/A-1 MADRIGAL PHARMACEUTICALS CMN 558868105 142,991 -20,800 -12.70 34,641 -27.14 0.0080
2023-05-11 2023-03-31 13F MADRIGAL PHARMACEUTICALS CMN 558868105 142,991 -20,800 34,641 0.0074
2024-05-14 2022-12-31 13F/A-1 MADRIGAL PHARMACEUTICALS CMN 558868105 163,791 -16,611 -9.21 47,540 432,081.82 0.0117
2023-02-13 2022-12-31 13F MADRIGAL PHARMACEUTICALS CMN 558868105 163,791 -16,611 47,540 0.0106
2024-05-14 2022-09-30 13F/A-1 MADRIGAL PHARMACEUTICALS CMN 558868105 180,402 127,776 242.80 12 266.67 0.0030
2022-11-14 2022-09-30 13F MADRIGAL PHARMACEUTICALS CMN 558868105 180,402 127,776 11,725 0.0027
2024-05-14 2022-06-30 13F/A-2 MADRIGAL PHARMACEUTICALS CMN 558868105 52,626 4,038 8.31 4 -99.94 0.0009
2022-08-18 2022-06-30 13F/A-1 MADRIGAL PHARMACEUTICALS CMN 558868105 52,626 4,038 3,767 0.0009
2022-08-15 2022-06-30 13F MADRIGAL PHARMACEUTICALS CMN 558868105 52,626 4,038 3,767 0.0008
2022-05-16 2022-03-31 13F MADRIGAL PHARMACEUTICALS CMN 558868105 48,588 -56,891 -53.94 4,767 -46.67 0.0010
2022-02-17 2021-12-31 13F/A-1 MADRIGAL PHARMACEUTICALS CMN 558868105 105,479 -49,691 -32.02 8,938 -27.81 0.0018
2022-02-14 2021-12-31 13F MADRIGAL PHARMACEUTICALS CMN 558868105 105,479 -49,691 8,938 0.0005
2022-01-20 2021-09-30 13F/A-1 MADRIGAL PHARMACEUTICALS CMN 558868105 155,170 45,883 41.98 12,381 16.30 0.0026
2021-11-10 2021-09-30 13F MADRIGAL PHARMACEUTICALS CMN 558868105 155,170 45,883 12,381 0.0026
2021-08-13 2021-06-30 13F MADRIGAL PHARMACEUTICALS CMN 558868105 109,287 20,441 23.01 10,646 2.44 0.0024
2021-05-17 2021-03-31 13F MADRIGAL PHARMACEUTICALS CMN 558868105 88,846 20,738 30.45 10,392 37.24 0.0026
2021-02-12 2020-12-31 13F MADRIGAL PHARMACEUTICALS CMN 558868105 68,108 -46,794 -40.73 7,572 -44.50 0.0019
2020-11-13 2020-09-30 13F MADRIGAL PHARMACEUTICALS CMN 558868105 114,902 10,305 9.85 13,643 15.17 0.0039
2020-08-12 2020-06-30 13F MADRIGAL PHARMACEUTICALS CMN 558868105 104,597 -97,270 -48.19 11,846 -12.10 0.0036
2020-05-15 2020-03-31 13F MADRIGAL PHARMACEUTICALS CMN 558868105 201,867 37,066 22.49 13,477 -10.24 0.0047
2020-02-14 2019-12-31 13F MADRIGAL PHARMACEUTICALS CMN 558868105 164,801 60,567 58.11 15,015 67.07 0.0038
2019-11-14 2019-09-30 13F MADRIGAL PHARMACEUTICALS CMN 558868105 104,234 -937 -0.89 8,987 -18.47 0.0026
2019-08-14 2019-06-30 13F MADRIGAL PHARMACEUTICALS CMN 558868105 105,171 -16,917 -13.86 11,023 -27.92 0.0032
2019-05-15 2019-03-31 13F MADRIGAL PHARMACEUTICALS CMN 558868105 122,088 34,378 39.20 15,292 54.68 0.0046
2019-02-14 2018-12-31 13F MADRIGAL PHARMACEUTICALS CMN 558868105 87,710 16,845 23.77 9,886 -34.85 0.0032
2018-11-14 2018-09-30 13F MADRIGAL PHARMACEUTICALS CMN 558868105 70,865 31,623 80.58 15,174 38.26 0.0039
2018-08-14 2018-06-30 13F MADRIGAL PHARMACEUTICALS CMN 558868105 39,242 36,536 1,350.18 10,975 3,373.10 0.0030
2018-05-15 2018-03-31 13F MADRIGAL PHARMACEUTICALS CMN 558868105 2,706 -2,287 -45.80 316 -31.00 0.0001
2018-02-14 2017-12-31 13F MADRIGAL PHARMACEUTICALS CMN 558868105 4,993 4,993 458 0.0001
2017-08-14 2017-06-30 13F MADRIGAL PHARMACEUTICALS CMN 558868105 0 -20,836 -100.00 0 -100.00
2017-05-18 2017-03-31 13F/A-1 MADRIGAL PHARMACEUTICALS CMN 558868105 20,836 8,793 73.01 321 109.80 0.0001
2017-05-15 2017-03-31 13F MADRIGAL PHARMACEUTICALS CMN 558868105 20,836 321
2016-11-14 2016-09-30 13F MADRIGAL PHARMACEUTICALS CMN 558868105 12,043 12,043 153 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-06-27 2025-03-31 13F/A MADRIGAL PHARMACEUTICALS CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-16 2025-03-31 13F/A MADRIGAL PHARMACEUTICALS CMN Call 0 0 n/a n/a n/a
2025-05-09 2025-03-31 13F MADRIGAL PHARMACEUTICALS CMN Call 0 0 n/a n/a n/a
2025-02-11 2024-12-31 13F MADRIGAL PHARMACEUTICALS CMN Call 10,700 0.00 3,302 45.42 n/a n/a n/a
2024-11-14 2024-09-30 13F MADRIGAL PHARMACEUTICALS CMN Call 10,700 0.00 2,271 -24.26 n/a n/a n/a
2024-08-13 2024-06-30 13F MADRIGAL PHARMACEUTICALS CMN Call 10,700 12.63 2,998 18.18 n/a n/a n/a
2024-05-15 2024-03-31 13F MADRIGAL PHARMACEUTICALS CMN Call 9,500 0.00 2,537 15.38 n/a n/a n/a
2024-03-01 2023-12-31 13F/A MADRIGAL PHARMACEUTICALS CMN Call 9,500 2,198 n/a n/a n/a
2024-05-14 2023-12-31 13F/A MADRIGAL PHARMACEUTICALS CMN Call 9,500 -71.89 2,198 -55.47 n/a n/a n/a
2024-02-13 2023-12-31 13F MADRIGAL PHARMACEUTICALS CMN Call 9,500 2,198 n/a n/a n/a
2024-05-15 2023-09-30 13F/A MADRIGAL PHARMACEUTICALS CMN Call 33,800 238.00 4,936 113.68 n/a n/a n/a
2023-11-14 2023-09-30 13F MADRIGAL PHARMACEUTICALS CMN Call 33,800 4,936 n/a n/a n/a
2024-05-14 2023-06-30 13F/A MADRIGAL PHARMACEUTICALS CMN Call 10,000 2,310 n/a n/a n/a
2023-08-15 2023-06-30 13F MADRIGAL PHARMACEUTICALS CMN Call 10,000 2,310 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-02-11 2024-12-31 13F MADRIGAL PHARMACEUTICALS CMN Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-14 2024-09-30 13F MADRIGAL PHARMACEUTICALS CMN Put 20,000 0.00 4,244 -24.25 n/a n/a n/a
2024-08-13 2024-06-30 13F MADRIGAL PHARMACEUTICALS CMN Put 20,000 5,603 n/a n/a n/a
2021-05-14 2021-03-31 13F MADRIGAL PHARMACEUTICALS CMN Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-12 2020-12-31 13F MADRIGAL PHARMACEUTICALS CMN Put 12,600 -44.25 1,401 -47.78 n/a n/a n/a
2020-11-13 2020-09-30 13F MADRIGAL PHARMACEUTICALS CMN Put 22,600 2,683 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.